Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
When an HIV infected person taking strong anti-HIV drugs temporarily stops taking them, viral
load rises and the body's immune system is exposed to more HIV. This may lead to the body
mounting a better immune response against the virus. The purpose of this study is to find out
if taking interleukin-2 (also called IL-2 or aldesleukin) while stopping anti-HIV drugs for
short periods of time can help patients control their HIV viral load.
Study hypothesis: Patients in this study will have lower virologic rebound and will maintain
their CD4 cell counts for a longer time than other patients in comparative studies.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)